via InvestorWire – Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare™ today announced that Jesse Ledger, President & Chief Financial Officer, will be attending the Q1 Virtual Investor Summit. 
    Event    Q1 Investor Summit    
      Date   March 23-25th, 2021  
    Presentation        March 24th @ 3:30PM ET  

About The Investor SummitThe Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website at

Contact: Brittney Blocker at

About MiravoMiravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada.  The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S., Canada and E.U. GMP regulations are regularly inspected by Health Canada and the U.S. Food and Drug Administration. 

For additional information, please visit

Wire Service Contact InvestorWire (IW) Los Angeles, California 212.418.1217 Office

Nuvo Pharmaceuticals (TSX:MRV)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Nuvo Pharmaceuticals Charts.
Nuvo Pharmaceuticals (TSX:MRV)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Nuvo Pharmaceuticals Charts.